Fabino Enterprises Ltd
BSE: FABINO
Prev Close
24.25
Open Price
23
Volume
3,000
Today Low / High
23 / 23
52 WK Low / High
22.8 / 38.96
Range
22 - 24
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 23, reflecting a change of -1.25 (-5.15464%). The expected target range on the BSE is 22 - 24. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Fabino Enterprises Ltd Graph
Fabino Enterprises Ltd Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Fabino Enterprises Ltd T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 23.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 23.00 | 23.23 | 20.91 - 25.55 |
| 23.46 | 18.77 - 28.15 | ||
| 23.69 | 16.58 - 30.80 | ||
| Bearish Scenario | 23.00 | 22.77 | 20.49 - 25.05 |
| 22.54 | 18.03 - 27.05 | ||
| 22.31 | 15.62 - 29.00 |
Overview of Fabino Enterprises Ltd
ISIN
INE0DRT01018
Industry
Medical - Pharmaceuticals
Vol.Avg
532
Market Cap
48,300,000
Last Dividend
0
Official Website
IPO Date
2024-12-30
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 18.04 Cr | 16.49 Cr | 1.55 Cr | 0.0858 | 0.00 Cr | 0.24 Cr | 0.03 Cr | 0.06 Cr | 0.28 | 0.40 Cr | 0.0034 |
| 2024-03-31 | 21.08 Cr | 20.05 Cr | 1.03 Cr | 0.0488 | 0.00 Cr | 0.15 Cr | 0.08 Cr | 0.04 Cr | 0.17 | 0.13 Cr | 0.0017 |
| 2023-03-31 | 3.36 Cr | 2.95 Cr | 0.41 Cr | 0.1220 | 0.00 Cr | 0.04 Cr | -0.01 Cr | 0.01 Cr | 0.05 | 0.05 Cr | 0.0032 |
| 2022-03-31 | 4.20 Cr | 3.58 Cr | 0.62 Cr | 0.1480 | 0.00 Cr | 0.07 Cr | 0.09 Cr | 0.05 Cr | 0.22 | 0.10 Cr | 0.0112 |
| 2021-03-31 | 3.06 Cr | 2.73 Cr | 0.32 Cr | 0.1058 | 0.00 Cr | 0.01 Cr | 0.05 Cr | 0.03 Cr | 0.14 | 0.06 Cr | 0.0099 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.24 Cr | 17.66 Cr | 13.45 Cr | 4.2080 Cr | 1.79 Cr | 1.55 Cr | 1.20 Cr | 0.55 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 11.6622 Cr |
| 2024-03-31 | 0.06 Cr | 15.36 Cr | 11.21 Cr | 4.1442 Cr | 1.27 Cr | 1.21 Cr | 1.33 Cr | 0.34 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 9.8985 Cr |
| 2023-03-31 | 0.24 Cr | 5.01 Cr | 0.90 Cr | 4.1146 Cr | 0.41 Cr | 0.16 Cr | 1.19 Cr | 0.15 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.4451 Cr |
| 2022-03-31 | 0.59 Cr | 4.62 Cr | 0.52 Cr | 4.1038 Cr | 0.05 Cr | -0.54 Cr | 1.71 Cr | 0.17 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.4096 Cr |
| 2021-03-31 | 0.07 Cr | 2.25 Cr | 0.95 Cr | 1.3027 Cr | 0.31 Cr | 0.24 Cr | 0.47 Cr | 0.16 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.5553 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.1234 Cr | -0.4186 Cr | 0.4769 Cr | -0.1656 Cr | 0.1818 Cr | 0.2438 Cr | -0.2890 Cr | 0.1880 Cr | 0.5219 Cr | 0.0000 Cr | 0.1317 Cr |
| 2024-03-31 | -0.7682 Cr | -0.2753 Cr | 0.8630 Cr | -1.0059 Cr | -0.1805 Cr | 0.0620 Cr | -0.2377 Cr | 0.0358 Cr | 0.8630 Cr | 0.0000 Cr | -0.1474 Cr |
| 2023-03-31 | -0.6752 Cr | -0.0107 Cr | 0.3396 Cr | -0.6819 Cr | -0.3464 Cr | 0.2425 Cr | -0.0067 Cr | 0.0108 Cr | 0.3596 Cr | 0.0000 Cr | 0.5217 Cr |
| 2022-03-31 | -1.8988 Cr | -0.0496 Cr | 2.4717 Cr | -1.9445 Cr | 0.5233 Cr | 0.5889 Cr | -0.0457 Cr | 0.0470 Cr | -0.2623 Cr | 0.0000 Cr | -1.2405 Cr |
| 2021-03-31 | -0.4499 Cr | -0.1004 Cr | 0.4474 Cr | -0.5437 Cr | -0.1029 Cr | 0.0655 Cr | -0.0938 Cr | 0.0302 Cr | -0.0876 Cr | 0.0000 Cr | -0.1743 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 6.90 Cr | 6.64 Cr | 0.26 Cr | 0.0378 | -0.15 Cr | 0.02 Cr | 0.08 | 0.07 Cr | 0.0024 |
| 2024-12-31 | 6.90 Cr | 6.64 Cr | 0.26 Cr | 0.0378 | -0.15 Cr | 0.02 Cr | 0.08 | 0.07 Cr | 0.0024 |
| 2024-09-30 | 2.13 Cr | 1.83 Cr | 0.30 Cr | 0.1390 | 0.24 Cr | 0.01 Cr | 0.07 | 0.07 Cr | 0.0066 |
| 2024-06-30 | 2.13 Cr | 1.83 Cr | 0.30 Cr | 0.1390 | 0.24 Cr | 0.01 Cr | 0.07 | 0.07 Cr | 0.0066 |
| 2024-03-31 | 4.11 Cr | 3.96 Cr | 0.16 Cr | 0.0379 | -0.26 Cr | -0.03 Cr | -0.12 | 0.00 Cr | -0.0064 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.24 Cr | 0.00 Cr | 0.24 Cr | 15.58 Cr | 1.20 Cr | 17.03 Cr | 0.55 Cr | 17.66 Cr | 13.45 Cr |
| 2024-12-31 | 0.24 Cr | 0.00 Cr | 0.24 Cr | 14.17 Cr | 1.20 Cr | 17.03 Cr | 0.55 Cr | 17.66 Cr | 13.45 Cr |
| 2024-09-30 | 0.04 Cr | 0.00 Cr | 0.04 Cr | 14.46 Cr | 3.45 Cr | 19.78 Cr | 0.33 Cr | 20.20 Cr | 16.03 Cr |
| 2024-06-30 | 0.04 Cr | 0.00 Cr | 0.04 Cr | 14.46 Cr | 3.45 Cr | 19.78 Cr | 0.33 Cr | 20.20 Cr | 16.03 Cr |
| 2024-03-31 | 0.06 Cr | 0.00 Cr | 0.06 Cr | 13.53 Cr | 1.33 Cr | 14.93 Cr | 0.34 Cr | 15.36 Cr | 11.21 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.02 Cr | 0.59 Cr | -0.16 Cr | -0.32 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -0.13 Cr | 0.46 Cr |
| 2024-12-31 | 0.02 Cr | 0.59 Cr | -0.16 Cr | -0.32 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -0.13 Cr | 0.46 Cr |
| 2024-09-30 | 0.01 Cr | -0.53 Cr | -0.05 Cr | 0.56 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -0.01 Cr | -0.54 Cr |
| 2024-06-30 | 0.01 Cr | -0.53 Cr | -0.05 Cr | 0.56 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -0.01 Cr | -0.54 Cr |
| 2024-03-31 | -0.03 Cr | -0.43 Cr | -0.14 Cr | 0.09 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -0.12 Cr | -0.55 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹763.10 | ₹91,376,415,181.00 | ₹234,880.00 |
Key Executives
Gender: male
Year Born:
Gender: female
Year Born:
FAQs about Fabino Enterprises Ltd
The CEO is Pankaj Jain.
The current price is ₹23.00.
The range is ₹22.8-38.96.
The market capitalization is ₹4.83 crores.
The P/E ratio is 77.78.
The company operates in the Healthcare sector.
Overview of Fabino Enterprises Ltd (ISIN: INE0DRT01018) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹4.83 crores and an average daily volume of 532 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.